Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

619

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Overall Survival
Interventions
DRUG

Dexmedetomidine

A loading dose of dexmedetomidine (0.6 μg/kg) was administered during a 10-minute period before anaesthesia induction, followed by a continuous infusion at a rate of 0.5 μg/kg/hr till 1 hour before the end of surgery.

DRUG

Placebo

Volume-matched normal saline was administered in the same rate for the same duration as in the intervention group.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT04111926 - Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery | Biotech Hunter | Biotech Hunter